Select Page
Home » Oral Dose » Oral Manufacturing » Scale-Up & Product Launch
Scale-Up & Product Launch

Scale-up is the process of increasing the batch size from laboratory-scale to commercial- scale and each project comes with its own set of challenges. Providing an effective and successful scale-up process that leads to a successful product launch is an art that not every manufacturing partner has mastered. Finding the ideal manufacturing partner relies heavily on the experience, knowledge, inventory of the equipment and capabilities of the manufacturing site. Being able to efficiently scale-up one program that requires small batch sizes to another program that requires larger batch sizes is essential. Flexibility is key. Having the ability to match each customers’ molecule with the right enabling technology is important for successful scale-up and eventual product launch for commercialization. Catalent’s integrated services from our early-phase sites to our late-phase sites provides a seamless transition for the scale-up of your program.

Getting a drug to market is an enduring process that requires coordination, an understanding of the project’s specific needs, risk management and experience. Product launches are an exciting time for pharmaceutical companies and for the patients they help. But getting to a product launch is a taxing endeavor. With increased regulations, supply chain challenges and FDA approval process, finding a reliable and experienced partner is essential.

Catalent has launched over 160 products a year. Our experience coupled with our state-of-the-art facilities in the U.S., Europe, Latin America, and Asia Pacific help us provide our customers with the services they need to have a successful product launch.